Published in J Biol Chem on August 01, 1957
Osteomalacia after prolonged glutethimide administration. Br Med J (1973) 1.67
Vitamin C: a concentration-function approach yields pharmacology and therapeutic discoveries. Adv Nutr (2011) 1.45
Vitamin C transporter Slc23a1 links renal reabsorption, vitamin C tissue accumulation, and perinatal survival in mice. J Clin Invest (2010) 1.33
Studies in detoxication. 84. The metabolism of [C]aniline in the rabbit and other animals. Biochem J (1960) 1.17
Stimulation of ascorbic acid synthesis and excretion by carcinogenic and other foreign compounds. Biochem J (1961) 1.10
METABOLISM OF D-GLUCURONOLACTONE IN MAMMALIAN SYSTEMS. 3. FURTHER STUDIES OF D-GLUCURONOLACTONE DEHYDROGENASE OF RAT LIVER. Biochem J (1963) 0.90
The stimulation of ascorbic acid excretion in rats. Br J Cancer (1962) 0.86
The influence of barbiturates on coumarin plasma levels and prothrombin response. J Clin Invest (1961) 0.75
Barbitone-induced tolerance to the effects of sedative-hypnotics and related compounds on operant behaviour in the rat. Br J Pharmacol (1979) 0.75
The physiological disposition of phenylbutazone (butazolidin) in man and a method for its estimation in biological material. J Pharmacol Exp Ther (1953) 3.60
The fate of pentobarbital in man and dog and a method for its estimation in biological material. J Pharmacol Exp Ther (1953) 2.38
A potent new uricosuric agent, the sulfoxide metabolite of the phenylbutazone analogue, G-25671. J Pharmacol Exp Ther (1957) 2.20
Adaptive increases in drug-metabolizing enzymes induced by phenobarbital and other drugs. J Pharmacol Exp Ther (1960) 2.04
Enzymatic dealkylation of aminopyrine (pyramidon) and other alkylamines. J Biol Chem (1955) 1.77
The metabolic fate of phenylbutazone (butazolidin) in man. J Pharmacol Exp Ther (1955) 1.76
Ascorbic acid synthesis in normal and drug-treated rats, studied with L-ascorbic-1-C14 acid. J Biol Chem (1954) 1.61
DRUG INTERACTIONS IN MAN. I. LOWERING EFFECT OF PHENOBARBITAL ON PLASMA LEVELS OF BISHYDROXYCOUMARIN (DICUMAROL) AND DIPHENYLHYDANTOIN (DILANTIN). Clin Pharmacol Ther (1965) 1.55
The synthesis of l-ascorbic acid by the albino rat. J Biol Chem (1950) 1.53
Metabolism of drugs in subjects with Laennec's cirrhosis. Med Exp Int J Exp Med (1959) 1.38
VARICELLA PNEUMONIA: A POSSIBLE CAUSE OF SUBSEQUENT PULMONARY CALCIFICATION. Med J Aust (1964) 1.36
Stimulatory effect of foreign compounds on ascorbic acid biosynthesis and on drug-metabolizing enzymes. Nature (1959) 1.26
Missing step in guinea pigs required for the biosynthesis of L-ascorbic acid. Science (1956) 1.22
Observations on the antirheumatic and physiologic effects of phenylbutazone (butazolidin) and some comparisons with cortisone. Am J Med (1954) 1.22
Results of a clinical trial of G-28315, a sulfoxide analog of phenylbutazone, as a uricosuric agent in gouty subjects. Arthritis Rheum (1958) 1.18
Metabolism of ascorbic acid and related uronic acids, aldonic acids, and pentoses. Ann N Y Acad Sci (1961) 1.15
Metabolic interactions between L-ascorbic acid and drugs. Ann N Y Acad Sci (1961) 1.12
The metabolism of 1-C14-L-ascorbic acid in guinea pigs. J Biol Chem (1951) 1.10
A study of the inverse relationship between pKa and rate of renal excretion of phenylbutazone analogs in man and dog. Am J Med (1960) 1.08
Biochemical pharmacological considerations of phenylbutazone and its analogues. Ann N Y Acad Sci (1960) 1.08
The biotransformation of ethyl biscoumacetate (tromexan) in man, rabbit and dog. J Pharmacol Exp Ther (1953) 1.08
The synthesis of L-ascorbic acid in the rat from D-glucuronolactone and L-gulonolactone. J Biol Chem (1956) 1.07
Phenylbutazone metabolites: antirheumatic, sodium-retaining and uricosuric effects in man. J Pharmacol Exp Ther (1958) 1.07
Metabolism of L-ascorbic acid-1-C14 in man. J Biol Chem (1958) 1.06
Studies on the glucuronic acid pathway of glucose metabolism. J Biol Chem (1959) 1.06
Missing step in man, monkey and guinea pig required for the biosynthesis of L-ascorbic acid. Nature (1957) 1.05
Zoxazolamine: physiological disposition, uricosuric properties. Am J Med (1958) 1.04
Observations on the drug-induced synthesis of D-glucuronic, L-gulonic and L-ascorbic acids in rats. J Pharmacol Exp Ther (1960) 1.03
STIMULATORY EFFECT OF PHENOBARBITAL ON THE METABOLISM OF DIPHENYLHYDANTOIN. J Pharmacol Exp Ther (1963) 1.02
The physiological disposition and fate of meperidine (demerol) in man and a method for its estimation in plasma. J Pharmacol Exp Ther (1955) 1.01
Intravenous anesthetics; new concepts. I. Experimental aspects. Curr Res Anesth Analg (1952) 0.98
Observations on G-25671, a phenylbutazone analogue (4-phenylthioethyl)-1,2-diphenyl 3,5-pyrazolidinedione). Proc Soc Exp Biol Med (1955) 0.97
Metabolism of L-gulonolactone in rats via pentose formation. Biochim Biophys Acta (1957) 0.97
Further observations on the metabolism of L-ascorbic acid in guinea pigs. J Biol Chem (1956) 0.97
The appearance of procaine in the spinal fluid during peridural block in man. J Pharmacol Exp Ther (1953) 0.96
APPLICATION OF DRUG METABOLISM TO DRUG TOXICITY STUDIES. Ann N Y Acad Sci (1965) 0.95
Observations on vitamin C activity of D-ascorbic acid. Proc Soc Exp Biol Med (1959) 0.95
Relationship between pKa and uricosuric activity in phenylbutazone analogues. Nature (1958) 0.95
INDUCED SYNTHESIS OF OXIDATIVE ENZYMES IN LIVER MICROSOMES BY POLYCYCLIC HYDROCARBONS AND DRUGS. Adv Enzyme Regul (1963) 0.94
Effect of a phenylbutazone analog (4-[phenylthioethyl]-1, 2-diphenyl 3, 5-pyrazolidinedione) on urate clearance and other discrete renal functions in gouty subjects; evaluation as uricosuric agent. J Clin Invest (1956) 0.93
BLOCKADE OF SOME METABOLIC EFFECTS OF CATECHOLAMINES BY N-ISOPROPYL METHOXAMINE (B.W. 61-43). J Pharmacol Exp Ther (1964) 0.92
The passage of thiopental into brain. J Pharmacol Exp Ther (1957) 0.91
Observations on the metabolic transformation and effects of phenylbutazone in subjects with hepatic disease. Am J Med Sci (1954) 0.91
IMPLICATIONS ON ENZYME INDUCTION FOR DRUG THERAPY. Am J Med (1964) 0.91
The passage of thiobarbiturates and their oxygen analogs into brain. J Pharmacol Exp Ther (1958) 0.90
Metabolism of sulfinpyrazone (Anturane) and other thio analogues of phenylbutazone in man. J Pharmacol Exp Ther (1961) 0.87
Metabolism of C14-labeled ascorbic, dehydroascorbic and diketoglulonic acids in guinea pigs. Arch Biochem Biophys (1959) 0.87
Conversion of myo-inositol to D-glucuronic acid and L-gulonic acid in the rat. Biochim Biophys Acta (1959) 0.87
ALTERATIONS IN ALBUMIN METABOLISM AFTER SERUM AND ALBUMIN INFUSIONS. J Clin Invest (1964) 0.86
The control of prothrombin activity with tromexan therapy. Am J Med (1953) 0.85
The physiological disposition of ethyl biscoumacetate (tromexan) in man and a method for its estimation in biological material. J Pharmacol Exp Ther (1952) 0.84
INHIBITION OF LIPID MOBILIZATION BY N-ISOPROPYL METHOXAMINE (B.W. 61-43). J Pharmacol Exp Ther (1964) 0.83
Metabolism of D-galactose to D-glucuronic acid, L-gulonic acid and L-ascorbic acid in normal and barbital-treated rats. Biochim Biophys Acta (1960) 0.82
Metabolism of L-ascorbic acid in rat kidney. J Biol Chem (1958) 0.82
Further observations on the biosynthesis of L-ascorbic acid from D-glucose in the rat. J Biol Chem (1956) 0.82
Studies on the incorporation of C14 administered as L-sorbose into L-ascorbic acid and D-glucose in rats. J Biol Chem (1955) 0.81
Biosynthesis of L-ascorbic acid; basic defect in scurvy. Am J Med (1959) 0.80
Studies of the mechanism of L-xylulose formation by kidney enzymes. J Biol Chem (1959) 0.80
The metabolic fate of zoxazolamine (flexin) in man. J Pharmacol Exp Ther (1960) 0.78
Formation of L-lyxonic and L-xylonic acids from L-ascorbic acid in rat kidney. J Biol Chem (1960) 0.77
The transmission of meperidine across the human placenta. Am J Obstet Gynecol (1952) 0.77
PHYSIOLOGICAL DISTRIBUTION AND METABOLIC INACTIVATION OF CHLORCYCLIZINE AND CYCLIZINE. J Pharmacol Exp Ther (1965) 0.77
Physiological disposition and metabolic fate of chlorzoxazone (paraflex) in man. J Pharmacol Exp Ther (1960) 0.77
MANAGEMENT OF COIN LESIONS AND CARCINOMA OF THE LUNG. Ann Surg (1965) 0.75
Pyogenic granuloma; multiple local recurrence following excision. Proc R Soc Med (1954) 0.75
Myocarditis. Med Press (1953) 0.75
ACUTE ARSENIC POISONING. Nebr State Med J (1965) 0.75
Role of ascorbic acid in the formation and maintenance of dental structures. Ann N Y Acad Sci (1961) 0.75
The aetiology and treatment of paroxysmal tachycardia. Med Press (1948) 0.75
An improved bipod for Boyle-Davis gag. Lancet (1955) 0.75
Effect of phenylbutazone (butazolidin) on experimentally induced ocular inflammation. AMA Arch Ophthalmol (1955) 0.75
THERAPEUTIC IMPLICATIONS OF DRUG METABOLISM. Semin Hematol (1964) 0.75
Observations on effect of 3-methylcholanthrene in scorbutic guinea pigs. Proc Soc Exp Biol Med (1961) 0.75
Physiological disposition of certain N-alkyl thiobarbiturates. Anesthesiology (1955) 0.75
LOWERING EFFECT OF NEOSTIGMINE ON PLASMA FREE FATTY ACIDS. Nature (1964) 0.75
Intravenous anesthesia; new concepts. II. Clinical aspects. Curr Res Anesth Analg (1952) 0.75
Tuberculous meningitis in children: a preventable illness. N C Med J (1956) 0.75
A case of respiratory inco-ordination. J Laryngol Otol (1946) 0.75
Hind-quarter amputation. Nurs Mirror Midwives J (1951) 0.75
Biochemical pharmacological considerations of zoxazolamine and chlorzoxazone metabolism. Ann N Y Acad Sci (1960) 0.75
Formation of L-xylulose from L-gulonic acid in rat kidney. Biochim Biophys Acta (1959) 0.75
Case for diagnosis (congenital heart disease with atrial septal defect); mitral stenosis? Proc R Soc Med (1946) 0.75
Malformation of the anus and rectum. J Med Soc N J (1958) 0.75
Stimulatory effect of chlorcyclizine on barbiturate metabolism. J Pharmacol Exp Ther (1961) 0.75
A p-nitro analogue of phenylbutazone possessing potent antirheumatic, sodium retaining and uricosuric properties. J Pharmacol Exp Ther (1959) 0.75
Water-soluble vitamins, Part I. (Ascorbic acid, nicotinic acid, vitamin B6, biotin, inositol). Annu Rev Biochem (1960) 0.75
Sites of sensory blockade during segmental spinal and segmental peridural anesthesia in man. Anesthesiology (1953) 0.75
Ophthalmic nursing. Corneal graft. Nurs Times (1961) 0.75
Physiologic disposition and uricosuric effect of a keto analog of oxyphenbutazone (G-29701). Arthritis Rheum (1960) 0.75